KP-496

N/A

Report date: 2022/01/24 16:05:01
NME

Base Information

Drug NameKP-496
Drug Alias NameS-36527S-36496KP-496NSKP-496
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCysteinyl leukotriene receptor 1 antagonistsThromboxane A2 synthase inhibitors
TargetsCysteinyl leukotriene receptor 1Thromboxane A2 synthase
Therapy Area/IndicationsRhinitis, AllergicAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesKaken Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKaken Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsRhinitis, AllergicAsthma

Other Information

ATC CodeN/A
Related LinksN/A